Experimental Drug Could Cut Migraine Frequency
THURSDAY, Aug. 19, 2021 (HealthDay News) — A new pill specifically designed to prevent migraines appears to do the job, a new clinical trial finds. Atogepant cut patients’ migraine days in half over 12 weeks of treatment, without causing serious side effects, the researchers said. Experts said the drug, ifContinue Reading